22 results
8-K
EX-10.2
TXMD
TherapeuticsMD Inc
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
notice or other communication from the FDA, USDA, FSIS, AMS, FTC, the Department of Justice, any state attorney general or any private enforcer acting … as a private attorney general or other Regulatory Authority or Governmental Entity, including any Warning Letter, Untitled Letter, notice of violation
424B3
p5eltcsn9bh0596rto
4 Nov 13
Prospectus supplement
12:00am
POS AM
xiz7d z0iuhr
9 Oct 13
Prospectus update (post-effective amendment)
12:00am
424B5
uo6ww jlh7w4avfrs6h
15 Mar 13
Prospectus supplement for primary offering
12:00am
424B3
rycwbi
12 Mar 13
Prospectus supplement
12:00am
424B5
g1w7m76n
7 Mar 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
gj2si6t1zqrcgq
25 Jan 13
Special Note Regarding Forward-Looking Statements
12:00am
424B3
mduiw jd8c5u1knwwg1
12 Dec 12
Prospectus supplement
12:00am
S-1
mxr0awo jujrag
27 Nov 12
IPO registration
12:00am